French summaries of product characteristics: Content in relation to therapeutic monitoring of psychotropic drugs

Fundamental and Clinical Pharmacology

Volumn 24, Issue 3, 2010, Pages 377-384

  Rougemont, Michael ^a   Ulrich, Sven ^b   Hiemke, Christoph ^c   Corruble, Emmanuelle ^d   Baumann, Pierre ^e  

^a BICÊTRE HOSPITAL   (France)

^b University of Mainz ^*  (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d Universite Paris Sud   (France)

^e DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

Author keywords

Psychotropic drugs; Summary of product characteristics; Therapeutic drug monitoring

Indexed keywords

ALPRAZOLAM; AMISULPRIDE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BROMAZEPAM; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; CLORAZEPATE; CLORAZEPATE DIPOTASSIUM; CLOZAPINE; DIAZEPAM; DOSULEPIN; HALOPERIDOL; HYPNOTIC AGENT; IMIPRAMINE; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; LORAZEPAM; MIDAZOLAM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE; TRANQUILIZER; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID;

ARTICLE; BREAST FEEDING; CLINICAL PRACTICE; DRUG BLOOD LEVEL; DRUG DOSE; DRUG INDUSTRY; DRUG INFORMATION; DRUG MONITORING; DRUG OVERDOSE; DRUG SAFETY; EVIDENCE BASED MEDICINE; FRANCE; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL;

DRUG LABELING; DRUG MONITORING; FRANCE; HUMANS; MENTAL DISORDERS; PRACTICE GUIDELINES AS TOPIC; PSYCHOTROPIC DRUGS;

EID: 77952580493     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00815.x     Document Type: Article

References (15)

1. Preskorn S.H. Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J. Clin. Psychiatry (1993) 54 (Suppl. 9) 14 34. (Pubitemid 23320768)
2. Mitchell P.B. Therapeutic drug monitoring of non-tricyclic antidepressant drugs. Clin. Chem. Lab. Med. (2004) 42 1212 1218. (Pubitemid 39600325)
3. Raggi M.A., Mandrioli R., Sabbioni C., Pucci V. Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions. Curr. Med. Chem. (2004) 11 279 296. (Pubitemid 38240208)
4. Mauri M.C., Volonteri L.S., Colasanti A., Fiorentini A., De Gaspari I.F., Bareggi S.R. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response. Clin. Pharmacokinet. (2007) 46 359 388. (Pubitemid 46686464)
5. Baumann P., Hiemke C., Ulrich S. et al. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry (2004) 37 243 265. (Pubitemid 39587052)
6. Bengtsson F. Therapeutic drug monitoring of psychotropic drugs TDM "nouveau". Ther. Drug Monit. (2004) 26 145 151. (Pubitemid 38501208)
7. Ulrich S., Hiemke C., Laux G. et al. Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidence. Pharmacopsychiatry (2007) 40 121 127. (Pubitemid 46915320)
8. Vidal 2007: le dictionnaire, 83rd edn. Vidal, Issy-les-Moulineaux, 2007.
9. Vidal 2008: le dictionnaire, 84th edn. Vidal, Issy-les-Moulineaux, 2008.
10. Mitchell P.B. Therapeutic drug monitoring of psychotropic medications. Br. J. Clin. Pharmacol. (2000) 49 303 312. (Pubitemid 30195272)
11. De Oliveira I.R., Do Prado-Lima P.A.S., Samuel-Lajeunesse B. Monitoring of tricyclic antidepressant plasma levels and clinical response: a review of the literature. Part II. Psychiatr. Psychobiol. (1989) 4 81 90.
12. De Oliveira I.R., Do Prado-Lima P.A.S., Samuel-Lajeunesse B. Monitoring of tricyclic antidepressant plasma levels and clinical response: a review of the literature. Part I. Psychiatr. Psychobiol. (1989) 4 81 90.
13. Vuille F., Amey M., Baumann P. Use of plasma level monitoring of antidepressants in clinical practice - towards an analysis of clinical utility. Pharmacopsychiatry (1991) 24 190 195.
14. Mann K., Hiemke C., Schmidt L.G., Bates D.W. Appropriateness of therapeutic drug monitoring for antidepressants in routine psychiatric inpatient care. Ther. Drug Monit. (2006) 28 83 88. (Pubitemid 44391699)
15. Mann K., Hiemke C., Lotz J., Schmidt L.G., Lackner K.J., Bates D.W. Appropriateness of plasma level determinations for lithium and valproate in routine care of psychiatric inpatients with affective disorders. J. Clin. Psychopharmacol. (2006) 26 671 673. (Pubitemid 44772752)